125 related articles for article (PubMed ID: 37158602)
1. Selectively attacking tumor cells of Ru/Ir-arene complexes based on meclofenamic acid
Huang Y; Lv M; Guo B; Hu G; Qian Y; Su Z; Xue X; Liu HK
Dalton Trans; 2023 May; 52(20):6922-6933. PubMed ID: 37158602
[TBL] [Abstract][Full Text] [Related]
2. Improving Cytotoxicity against Breast Cancer Cells by Using Mixed-Ligand Ruthenium(II) Complexes of 2,2'-Bipyridine, Amino Acid, and Nitric Oxide Derivatives as Potential Anticancer Agents.
Gaspari APS; da Silva RS; Carneiro ZA; de Carvalho MR; Carvalho I; Pernomian L; Ferreira LP; Ramos LCB; de Souza GA; Formiga ALB
Anticancer Agents Med Chem; 2021; 21(12):1602-1611. PubMed ID: 33081686
[TBL] [Abstract][Full Text] [Related]
3. A lysosome-targeted ruthenium(II) polypyridyl complex as photodynamic anticancer agent.
Chen J; Tao Q; Wu J; Wang M; Su Z; Qian Y; Yu T; Wang Y; Xue X; Liu HK
J Inorg Biochem; 2020 Sep; 210():111132. PubMed ID: 32569884
[TBL] [Abstract][Full Text] [Related]
4. Nitro-imidazole-based ruthenium complexes with antioxidant and anti-inflammatory activities.
Sasahara GL; Gouveia Júnior FS; Rodrigues RO; Zampieri DS; Fonseca SGDC; Gonçalves RCR; Athaydes BR; Kitagawa RR; Santos FA; Sousa EHS; Nagao-Dias AT; Lopes LGF
J Inorg Biochem; 2020 May; 206():111048. PubMed ID: 32151873
[TBL] [Abstract][Full Text] [Related]
5. Unlocking the potential of iridium and ruthenium arene complexes as anti-tumor and anti-metastasis chemotherapeutic agents.
Lv M; Qian X; Li S; Gong J; Wang Q; Qian Y; Su Z; Xue X; Liu HK
J Inorg Biochem; 2023 Jan; 238():112057. PubMed ID: 36370504
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxic Ruthenium(II) Complexes Containing a Dangling Pyridine: Selectivity for Diseased Cells Mediated by pH-Dependent DNA Binding.
Sangeetha S; Murali M
Inorg Chem; 2022 Feb; 61(6):2864-2882. PubMed ID: 35099196
[TBL] [Abstract][Full Text] [Related]
7. Cyclometalated Ru(II)-isoquinoline complexes overcome cisplatin resistance of A549/DDP cells by downregulation of Nrf2 via Akt/GSK-3β/Fyn pathway.
Chen L; Wang J; Cai X; Chen S; Zhang J; Li B; Chen W; Guo X; Luo H; Chen J
Bioorg Chem; 2022 Feb; 119():105516. PubMed ID: 34856444
[TBL] [Abstract][Full Text] [Related]
8. Ruthenium(ii) arene NSAID complexes: inhibition of cyclooxygenase and antiproliferative activity against cancer cell lines.
Mandal P; Kundu BK; Vyas K; Sabu V; Helen A; Dhankhar SS; Nagaraja CM; Bhattacherjee D; Bhabak KP; Mukhopadhyay S
Dalton Trans; 2018 Jan; 47(2):517-527. PubMed ID: 29235601
[TBL] [Abstract][Full Text] [Related]
9. Investigation into antiproliferative activity and apoptosis mechanism of new arene Ru(ii) carbazole-based hydrazone complexes.
Sathiya Kamatchi T; Mohamed Subarkhan MK; Ramesh R; Wang H; Małecki JG
Dalton Trans; 2020 Aug; 49(32):11385-11395. PubMed ID: 32776042
[TBL] [Abstract][Full Text] [Related]
10. New organoruthenium compounds with pyrido[2',3':5,6]pyrazino[2,3-f][1, 10]phenanthroline: synthesis, characterization, cytotoxicity, and investigation of mechanism of action.
Pavlović M; Nikolić S; Gligorijević N; Dojčinović B; Aranđelović S; Grgurić-Šipka S; Radulović S
J Biol Inorg Chem; 2019 Mar; 24(2):297-310. PubMed ID: 30762123
[TBL] [Abstract][Full Text] [Related]
11. Novel cyclometalated Ru(II) complexes containing isoquinoline ligands: Synthesis, characterization, cellular uptake and in vitro cytotoxicity.
Chen J; Wang J; Deng Y; Li B; Li C; Lin Y; Yang D; Zhang H; Chen L; Wang T
Eur J Med Chem; 2020 Oct; 203():112562. PubMed ID: 32698112
[TBL] [Abstract][Full Text] [Related]
12. Anti-metastasis and anti-proliferation effect of mitochondria-accumulating ruthenium(II) complexes via redox homeostasis disturbance and energy depletion.
Xie L; Wang L; Guan R; Ji L; Chao H
J Inorg Biochem; 2021 Apr; 217():111380. PubMed ID: 33578250
[TBL] [Abstract][Full Text] [Related]
13. Effect of
Mukherjee A; Acharya S; Purkait K; Chakraborty K; Bhattacharjee A; Mukherjee A
Inorg Chem; 2020 May; 59(9):6581-6594. PubMed ID: 32295347
[TBL] [Abstract][Full Text] [Related]
14. Systematic evaluation of the antitumor activity of three ruthenium polypyridyl complexes.
Jiang GB; Zhang WY; He M; Gu YY; Bai L; Wang YJ; Yi QY; Du F
J Inorg Biochem; 2021 Dec; 225():111616. PubMed ID: 34555601
[TBL] [Abstract][Full Text] [Related]
15. Half-sandwich organometallic Ru and Rh complexes of (N,N) donor compounds: effect of ligand methylation on solution speciation and anticancer activity.
Mészáros JP; Pape VFS; Szakács G; Németi G; Dénes M; Holczbauer T; May NV; Enyedy ÉA
Dalton Trans; 2021 Jun; 50(23):8218-8231. PubMed ID: 34032247
[TBL] [Abstract][Full Text] [Related]
16. Catch and Release Photosensitizers: Combining Dual-Action Ruthenium Complexes with Protease Inactivation for Targeting Invasive Cancers.
Arora K; Herroon M; Al-Afyouni MH; Toupin NP; Rohrabaugh TN; Loftus LM; Podgorski I; Turro C; Kodanko JJ
J Am Chem Soc; 2018 Oct; 140(43):14367-14380. PubMed ID: 30278123
[TBL] [Abstract][Full Text] [Related]
17. Phenylazo-pyridine and phenylazo-pyrazole chlorido ruthenium(II) arene complexes: arene loss, aquation, and cancer cell cytotoxicity.
Dougan SJ; Melchart M; Habtemariam A; Parsons S; Sadler PJ
Inorg Chem; 2006 Dec; 45(26):10882-94. PubMed ID: 17173447
[TBL] [Abstract][Full Text] [Related]
18. The biological effect of the nitroimidazole derivative of a polypyridyl ruthenium complex on cancer and endothelial cells.
Mazuryk O; Suzenet F; Kieda C; Brindell M
Metallomics; 2015 Mar; 7(3):553-66. PubMed ID: 25711770
[TBL] [Abstract][Full Text] [Related]
19. Ruthenium Complexes as Anticancer Agents: A Brief History and Perspectives.
Lee SY; Kim CY; Nam TG
Drug Des Devel Ther; 2020; 14():5375-5392. PubMed ID: 33299303
[TBL] [Abstract][Full Text] [Related]
20. Metal complexes as DNA intercalators.
Liu HK; Sadler PJ
Acc Chem Res; 2011 May; 44(5):349-59. PubMed ID: 21446672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
